Masimo Corporation (MASI)

USD 170.63

(-1.98%)

Revenue Summary of Masimo Corporation

  • Masimo Corporation's latest annual revenue in 2023 was 2.04 Billion USD , up 0.6% from previous year.
  • Masimo Corporation's latest quarterly revenue in 2024 Q3 was 504.6 Million USD , up 1.67% from previous quarter.
  • Masimo Corporation reported a annual revenue of 2.03 Billion USD in annual revenue 2022, up 64.29% from previous year.
  • Masimo Corporation reported a annual revenue of 1.23 Billion USD in annual revenue 2021, up 8.34% from previous year.
  • Masimo Corporation reported a quarterly revenue of 496.3 Million USD for 2024 Q2, up 0.71% from previous quarter.
  • Masimo Corporation reported a quarterly revenue of 492.8 Million USD for 2024 Q1, down -10.22% from previous quarter.

Annual Revenue Chart of Masimo Corporation (2023 - 1998)

Historical Annual Revenue of Masimo Corporation (2023 - 1998)

Year Revenue Revenue Growth
2023 2.04 Billion USD 0.6%
2022 2.03 Billion USD 64.29%
2021 1.23 Billion USD 8.34%
2020 1.14 Billion USD 21.96%
2019 937.83 Million USD 9.27%
2018 858.28 Million USD 7.54%
2017 798.1 Million USD 14.9%
2016 694.62 Million USD 10.24%
2015 630.11 Million USD 7.41%
2014 586.64 Million USD 7.2%
2013 547.24 Million USD 10.95%
2012 493.23 Million USD 12.36%
2011 438.98 Million USD 8.28%
2010 405.4 Million USD 16.12%
2009 349.11 Million USD 13.69%
2008 307.07 Million USD 19.82%
2007 256.28 Million USD 14.24%
2006 224.33 Million USD 107.93%
2005 107.89 Million USD 55.56%
2004 69.35 Million USD 48.41%
2003 46.73 Million USD 20.35%
2002 38.83 Million USD 0.0%
1999 6.7 Million USD 294.12%
1998 1.7 Million USD 0.0%

Peer Revenue Comparison of Masimo Corporation

Name Revenue Revenue Difference
Akoya Biosciences, Inc. 96.63 Million USD -2019.462%
AngioDynamics, Inc. 303.91 Million USD -573.908%
AtriCure, Inc. 399.24 Million USD -412.993%
Avinger, Inc. 7.65 Million USD -26665.551%
Azenta, Inc. 665.07 Million USD -207.952%
BioLife Solutions, Inc. 143.27 Million USD -1329.529%
The Cooper Companies, Inc. 3.59 Billion USD 43.001%
Daxor Corporation 1.28 Million USD -159843.46%
Ekso Bionics Holdings, Inc. 18.27 Million USD -11104.661%
Femasys Inc. 1.07 Million USD -190959.451%
GlucoTrack, Inc. - USD -Infinity%
Harvard Bioscience, Inc. 112.25 Million USD -1724.588%
Hologic, Inc. 4.03 Billion USD 49.182%
ICU Medical, Inc. 2.25 Billion USD 9.341%
Intuitive Surgical, Inc. 7.12 Billion USD 71.251%
KORU Medical Systems, Inc. 28.51 Million USD -7081.864%
LeMaitre Vascular, Inc. 193.48 Million USD -958.537%
Innovative Eyewear, Inc. 1.15 Million USD -177612.566%
Innovative Eyewear, Inc. 1.15 Million USD -177612.566%
Microbot Medical Inc. - USD -Infinity%
Meihua International Medical Technologies Co., Ltd. 97.09 Million USD -2009.292%
Merit Medical Systems, Inc. 1.25 Billion USD -62.888%
Nephros, Inc. 14.23 Million USD -14284.745%
NovoCure Limited 509.33 Million USD -302.11%
NEXGEL, Inc. 4.08 Million USD -49988.041%
NEXGEL, Inc. 4.08 Million USD -49988.041%
Singular Genomics Systems, Inc. 2.91 Million USD -70257.266%
OraSure Technologies, Inc. 405.47 Million USD -405.115%
Pro-Dex, Inc. 53.84 Million USD -3703.766%
Pulse Biosciences, Inc. - USD -Infinity%
Predictive Oncology Inc. 1.78 Million USD -114955.786%
Precision Optics Corporation, Inc. 19.1 Million USD -10620.595%
QuidelOrtho Corporation 2.99 Billion USD 31.68%
Repligen Corporation 638.76 Million USD -220.635%
Sanara MedTech Inc. 64.98 Million USD -3051.416%
STAAR Surgical Company 322.41 Million USD -535.237%
Sharps Technology, Inc. - USD -Infinity%
Utah Medical Products, Inc. 50.22 Million USD -3977.931%
DENTSPLY SIRONA Inc. 3.96 Billion USD 48.346%
Jin Medical International Ltd. 19.82 Million USD -10232.742%